Background {#Sec1}
==========

Canine ocular onchocercosis caused by *Onchocerca lupi* is a zoonotic parasite, which causes ocular conditions primarily in dogs. Since its original retrieval in the sclera of a wolf (*Canis lupus*) in Georgia \[[@CR1]\], this nematode has been detected in dogs in Hungary \[[@CR2]\], Greece \[[@CR3]--[@CR6]\], Germany \[[@CR7]\], Portugal \[[@CR4], [@CR8]\] and Romania \[[@CR9]\]. In addition, it has been identified in both dogs and cats in the USA \[[@CR10], [@CR11]\], and, more recently, in a cat in southern Portugal \[[@CR12]\].

Adult nematodes are generally embedded in granulomatous nodules in ocular retrobulbar space, orbital fascia, eyelid, third palpebra, conjunctiva and sclera \[[@CR13]\]. Infection by *O. lupi* causes lesions ranging from no apparent clinical sings to conjunctivitis, photophobia, lacrimation, ocular discharge, keratitis, uveitis, exophthalmos and even blindness \[[@CR14], [@CR15]\].

Accordingly, the diagnosis of *O. lupi* relies on the detection of microfilariae in skin snips \[[@CR15]\] and may also be investigated by the use of imaging tools (i.e. ultrasound scans, computed tomography and magnetic resonance imaging - MRI) \[[@CR16]\].

The zoonotic potential of *O. lupi* has been demonstrated in Tunisia, Turkey, Iran and USA \[[@CR17]\], with an increasing interest of the scientific community in investigating the definitive and intermediate hosts of this nematode as well as the range of distribution of the infection it causes. Therefore, this study aims at investigating the occurrence of canine onchocercosis in dogs from the southwestern region of Spain.

Methods {#Sec2}
=======

Study area and sample procedures {#Sec3}
--------------------------------

Dogs were recruited among those living in an animal shelter in the municipality of Valverde del Camino, Huelva in the Southwest of Spain (latitude 37°34\'20\"N; longitude: 6°45\'12\"W; altitude: 272 m above sea level).

One hundred and four adult dogs (older than one year) receiving no treatment against ecto- and/or endoparasites were sampled. For each animal, data on breed, age, gender, weight, health status (including ocular signs) and place of origin were recorded in a clinical file. All dogs were subjected to a thorough physical examination followed by an eye examination after the administration of anaesthetic eye drops (tetracaine hydrochloride and naphazoline hydrochloride, Colircusí Anestésico® 0.50 %, ALCON). Skin snip samples were obtained from each animal. Skin snip samples were collected using a disposable scalpel over an area of ≈ 0.2 × 0.2 × 0.2 cm from the forehead and interscapular region and stored in aliquots containing 0.5 ml of saline solution (NaCl 0.9 %) at room temperature until examination under a microscope and processing for PCR.

Sample processing {#Sec4}
-----------------

Skin samples in saline were centrifuged at 1500 rpm for 3 min and sediments (20 μl) from these aliquots were individually observed under a light microscope. Microfilariae were identified based on their morphological features that is, in brief, presence of short flattened unsheathed body (mean length 110.1 ± 7.5 μm, width 6.8 ± 1.2 μm) with a rounded head bearing a tiny tooth in the cephalic region \[[@CR18]\].

Skin samples were processed for molecular amplification and sequencing of the partial cytochrome oxidase subunit 1 (*cox*1) gene, according to a PCR procedure previously described \[[@CR4]\].

Imaging diagnosis {#Sec5}
-----------------

A MRI study was only conducted in two dogs testing PCR-positive for *O. lupi*, because the other three positive dogs were previously adopted. After a thorough neurological and eye exam, MRI was performed with the two dogs in a sternal recumbent position under general anaesthesia, induced with propofol (Vetofol® 10 mg/ml, 0.5--1 mg/kg as needed) and maintained with isofluorane (Isoflo®, 1.5 % spontaneous ventilation).

Images were acquired by using a 0.2 Tesla MRI machine (ESAOTE VetMR), at slice thicknesses of 4 mm in the dorsal and sagittal planes and 4.5 mm in the transverse plane. T2-weighted images were examined in three planes (dorsal Gradient Echo T2). Transverse FLAIR and T1-weighted images (transverse and dorsal) were also examined with and without contrast (gadoteric acid 0.5 mmol/ml- Dotarem® 0.2 ml/kg). During the recovery time from anaesthesia, the two dogs were also subjected to ocular ultrasonography in which a 10 MHz transducer (ESAOTE MyLab 40) was gently applied to the cornea via a small amount of viscous coupling gel.

Ethical considerations {#Sec6}
----------------------

The study was carried out in accordance with Spanish Legislation guidelines (Ley 11/2003, Comunidad Autónoma de Andalucía) and the International Guiding Principles for Biomedical Research Involving Animals, issued by the Council for the International Organizations of Medical Sciences.

Results and discussion {#Sec7}
======================

Mean age and weight of the 104 dogs examined were 3.82 years (standard deviation (SD): 2.87) and 25.99 kg (SD: 14.04), respectively. In the population sampled there was a biased proportion towards males (70 %).

Five out of 104 tested dogs (4.8 %) were skin snip-positive for *O. lupi*: two by light microscopy and three by PCR (Table [1](#Tab1){ref-type="table"}), with an overall prevalence of 4.8 % lower than that reported in Portugal (8.3 %) and Greece (8.7 %) \[[@CR4]\].Table 1Detailed results of different techniques used on skin-snip of the five dogs testing positiveAnimal IDSkin samplesMicroscopy examinationPCR (NTF/NTR) plus sequence analysis1NEG99 % KX132091 *O. lupi* h12NEG100 % KC686701 *O. lupi* h13*O. lupi*NEG4*O. lupi*NEG5NEG100 % KC686701 *O. lupi* h1

This is the first report of *O. lupi* in Spain and the first epidemiological study on this helminthic infection, since only one epidemiological study has been undertaken in Greece and Portugal \[[@CR4]\] in areas where the presence of *O. lupi* in dogs had been previously recorded. Any of the dogs herein tested presented ocular lesions or other clinical signs, similar to the findings of the previous epidemiological study conducted in Portugal and Greece \[[@CR4]\], in which *O. lupi* microfilariae were diagnosed in skin snip sediments of the asymptomatic animals sampled. In the present study, one of the *O. lupi* infected dogs showed neurological abnormalities, although previous studies have not reported this clinical sign in dogs positive to *O. lupi*. However, this condition was described in a 13-year-old boy presenting neurological signs due to aberrant epidural cervical infection, in the spinal canal, by adult nematodes \[[@CR19]\]. However, since an aberrant laryngeal location of *O. lupi* was previously reported in a dog from Portugal \[19\], the dog with neurological signs is referred to as (dog 1, Table [1](#Tab1){ref-type="table"}) and one without those signs as (dog 4, Table [1](#Tab1){ref-type="table"}), were subjected to imaging tests to detect the presence of adults or nodules containing *O. lupi* adults. No granulomatous nodules were detected by this technique although it would have been interesting to examine the remaining animals using imaging techniques.

*O. lupi* microfilariae were detected in skin samples by microscopy examination in two dogs and in three other dogs by PCR diagnosis (*n* = 3). PCR products were sequenced compared to those available in GenBank. Sequences showed a 100 % (*n* = 2) nucleotide identity with those of *O. lupi* in the GenBank database (AN = KC686701). The sequence from another nematode displayed 99 % sequence homology (*n* = 1) with the sequence above, therefore representing a new sequence haplotype (AN = KX132091). It is noteworthy that skin samples from two dogs were microscopy positive for *O. lupi* but PCR negative; this could be because the parasite massively migrated from the skin to saline solution with only the microfilariae being detected in the sediment. Otranto et al. reported a greater number of microfilaria were observed in the sediment when the skin sample was stored for a longer time in the saline solution \[[@CR15]\]. On the other hand, three dogs were PCR positive but negative at microscopy for *O. lupi*; this could be explained because microfilariae could not be observed in the sediment due to the presence of low parasite load.

Conclusion {#Sec8}
==========

This first report of *O. lupi* infection in dogs in southern Spain expands the range of geographical distribution of this parasite and sounds an alarm bell for practitioners and physicians working in that area. In an investigation underway, the clinical impacts of infection in affected dogs and the epidemiological factors influencing the presence of this unknown parasite are being examined.
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